Vaccinex, Inc. (VCNX): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-14, first reflected in a filing dated 2024-04-02. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

2.68M

As of 2024-12-31

2017-12-31 Shares Outstanding (shares) 2024-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2024-12-31	2.68M	+199.9%	2025-04-15, Balance as of period end
2023-12-31	892.6K	+275.8%	2025-04-15, Balance as of period end
2022-12-31	237.5K	n/c	2024-04-25, Balance as of period end
2021-12-31	30.80M	+37.6%	2023-03-31, Balance as of period end
2020-12-31	22.39M	n/c	2022-03-31, Balance as of period end
2019-12-31	14.89M	+29.7%	2021-03-31, Balance as of period end
2018-12-31	11.48M	n/c	2020-03-09, Balance as of period end
2017-12-31	1.10M	n/a	2019-03-13, Balance as of period end